Bibliography
- Hansch C, Fujita T. rho-sigma-pi Analysis. A method for the correlation of biological activity and chemical structure. J Am Chem Soc 1964;86:1616-26
- Rekker RF. The hydrophobic fragmental constant Elsevier, Amsterdam; 1977
- Ganellin R. Robin Ganellin gives his views on medicinal chemistry and drug discovery. Drug Discov Today 2004;9:158-60
- Puzyn T, Leszczynski J, Cronin MT. Recent advances in QSAR studies. In challenges and advances in computational chemistry and physics. Volume 8; 2010
- Kubinyi H. The long road from QSAR to virtual screening to drugs? Available from: www.kubinyi.de
- Hansch C. A quantitative approach to biological structure-activity relationships. Acc Chem Res 1969; 2:232-9
- Martin EJ, Sullivan DC. AutoShim: empirically corrected scoring functions for quantitative docking with a crystal structure and IC50 training data. J Chem Inf Model 2008;48(4):861-72
- Martin EJ, Sullivan DC. Surrogate autoshim: predocking into a universal ensemble kinase receptor for three dimensional activity prediction, very quickly, without a crystal structure. J Chem Inf Model 2008;48(4):873-81
- Langer T. Pharmacophores in drug research. Mol Inf 2010;29:470-75. 9
- Domling A. Small molecular weight protein-protein interactions antagonists - an insurmountable challenge. Curr Opin Chem Biol 2008;12:281-91
- Agrafiotis DK, Wiener JJM. Scaffold Explorer: an interactive tool for organizing and mining SAR data spanning multiple chemotypes. J Med Chem 2010;53(13):5002-11
- Agrafiotis DK, Shemanarev M, Connolly PJ, SAR maps: a new SAR visualization technique for medicinal chemists. J Med Chem 2007;50(24):5926-37
- Kolpak J, Connolly PJ, Lobanov VS, Agrafiotis DK. Enhanced SAR maps: expanding the data rendering capabilities of a popular medicinal chemistry tool. J Chem Inf Model 2009;49:2221-30
- van de Waterbeemd H. Improving compound quality through in vitro and in silico physicochemical profiling. Chem Biodiv 2009;6:1760-6
- Rodgers SL, Davis AM, Tomkinson NP, van de Waterbeemd H. QSAR modeling using automatically updating correction libraries: application to a human plasma protein binding model. J Chem Inf Model 2007;47:2401-7
- Kenny P. Hydrogen bonding, electrostatic potential, and molecular design. J Chem Inf Model 2009;49(5):1234-44
- Testa B. Drug metabolism for the perplexed medicinal chemist. Chem Biodivers 2009;6:2055-70
- Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20
- Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22:11-23
- Hansch C, Hoekman D, Leo A, The expanding role of quantitative structure-activity relationships (QSAR) in toxicology. Toxicol Lett 1995;79:45-53
- Selent J, Bauer-Mehren A, Lopez L, A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints. ChemMedChem 2008;3:1194-98
- Available from: http://www.imi.europa.eu/
- Keiser MJ, Setola V, Irwin JJ, Predicting new molecular targets for known drugs. Nature 2009;462:175-81
- Hansch C, Muir RM, Fujita T, The correlation of biological activity of plant growth regulators and chloromycetin derivatives with Hammett constants and partition coefficients. J Am Chem Soc 1963;85:18, 2817-24
- Searls DB. Data integration: challenges for drug discovery. Nature Rev Drug Discov 2005;4:45-58
- Available from: http://www.efmc.info/